Literature DB >> 11223432

Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries.

D A Tulis1, W Durante, K J Peyton, A J Evans, A I Schafer.   

Abstract

The heme oxygenase-1 (HO-1) system of heme catabolism has been proposed to exert protective actions upon the cardiovascular system. This investigation examined the influence of HO-1 induction on vascular remodeling following arterial injury. Rats were subjected to left carotid artery (LCA) balloon injury following pre-treatment with either vehicle, the HO-1 inducer hemin (50 mg/kg, SC), or concomitant treatment with hemin and the HO-1 inhibitor tin-protoporphyrin IX (SnPP-IX; 50 micromol/kg, IP). Animals were injected daily for 14 days post-injury, after which animals were sacrificed and tissues obtained. Western blot analyses revealed vascular HO-1 induction after 2 and 16 days of hemin treatment. Positive immunostaining for HO-1 was detected in the endothelial and adventitial layers following 48 h of hemin treatment and positive medial staining for HO-1 after 16 days of hemin treatment. The injured LCA of hemin-treated animals demonstrated significantly attenuated neointimal (NI) area (-57%), NI thickness (-58%), and NI area/medial wall area ratio (-40%) compared to the injured LCA of vehicle controls. The cross-sectional medial wall areas of both LCA and uninjured RCA were also significantly reduced in the hemin-treated animals. SnPP-IX treatment, however, completely restored the NI area, NI thickness, NI area/medial wall area ratio, and partially restored the medial wall area towards control levels. These results directly implicate HO-1 and the products of heme catabolism in attenuating the arterial response to injury and ensuing vascular wall remodeling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223432     DOI: 10.1016/s0021-9150(00)00552-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  40 in total

Review 1.  Novel therapies for cyclic GMP control of vascular smooth muscle growth.

Authors:  David A Tulis
Journal:  Am J Ther       Date:  2008 Nov-Dec       Impact factor: 2.688

2.  Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries.

Authors:  D A Tulis; A N Keswani; K J Peyton; H Wang; A I Schafer; W Durante
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2005-10-03       Impact factor: 1.770

Review 3.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

4.  Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1.

Authors:  Casey E Romanoski; Nam Che; Fen Yin; Nguyen Mai; Delila Pouldar; Mete Civelek; Calvin Pan; Sangderk Lee; Ladan Vakili; Wen-Pin Yang; Paul Kayne; Imran N Mungrue; Jesus A Araujo; Judith A Berliner; Aldons J Lusis
Journal:  Circ Res       Date:  2011-07-07       Impact factor: 17.367

5.  Protodioscin protects PC12 cells against oxygen and glucose deprivation-induced injury through miR-124/AKT/Nrf2 pathway.

Authors:  Kun Shu; Yuelin Zhang
Journal:  Cell Stress Chaperones       Date:  2019-08-24       Impact factor: 3.667

Review 6.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

7.  Histological and morphometric analyses for rat carotid balloon injury model.

Authors:  David A Tulis
Journal:  Methods Mol Med       Date:  2007

Review 8.  Use of carbon monoxide as a therapeutic agent: promises and challenges.

Authors:  Roberta Foresti; Mohamed G Bani-Hani; Roberto Motterlini
Journal:  Intensive Care Med       Date:  2008-02-20       Impact factor: 17.440

9.  Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells.

Authors:  Natalia N Mendelev; Verietta S Williams; David A Tulis
Journal:  J Cardiovasc Pharmacol       Date:  2009-02       Impact factor: 3.105

10.  AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury.

Authors:  Joshua D Stone; Avinash Narine; Patti R Shaver; Jonathan C Fox; Jackson R Vuncannon; David A Tulis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.